文献速递免疫规划

含H3N2跨膜结构域的血凝素与M1组装的H7病毒样颗粒在小鼠中诱导广泛的同源和异源保护

H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice.
PubMed 文献 · Vaccine · 2018-07-07

研究评估了两种H7病毒样颗粒(VLP)的生化特性和免疫原性:由野生型血凝素(HA-WT)或跨膜结构域替换为H3N2亚型(HA-TM)的血凝素与基质蛋白1(M1)组装而成。H7 VLPs-TM比H7 VLPs-WT具有更多三聚体HA蛋白且更耐热变化,在小鼠中诱导更高的HI、IgG、IgG2a和IFN-γ滴度,并对同源和异源H7N9病毒攻击提供更好的保护,体重丢失更少、存活率更高。

要点

  • H7 VLPs-TM较H7 VLPs-WT具有更多三聚体HA蛋白且更耐热变化。
  • H7 VLPs-TM在小鼠中诱导更高的HI、IgG、IgG2a和IFN-γ滴度。
  • H7 VLPs-TM对同源和异源H7N9病毒攻击提供更好保护,体重丢失更少、存活率更高。

核心结论

  • H7 VLPs-TM是开发H7N9疫苗的一种潜在策略。

研究设计与样本

  • 研究评估了由M1与HA-WT或HA-TM组成的两种H7 VLPs的生化特性和免疫原性,并在小鼠中进行了同源和异源H7N9病毒攻击保护试验。

主要发现

  • H7 VLPs-WT和H7 VLPs-TM均可在Sf9细胞上清中组装和释放,且具有相似的形态学特征。
  • 与H7 VLPs-WT相比,H7 VLPs-TM具有更多三聚体HA蛋白且更能抵抗热变化。
  • 在小鼠中,H7 VLPs-TM诱导的HI、IgG、IgG2a和IFN-γ滴度高于H7 VLPs-WT。
  • H7 VLPs-TM对同源和异源H7N9病毒(无论属于长江三角洲还是珠江三角洲)攻击提供更好的保护,体重丢失更少且存活率更高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza A H7N9 virus has caused five outbreak waves of human infections in China since 2013 and posed a dual challenge to public health and poultry industry. There is an urgent need to develop an effective vaccine to reduce its pandemic potential. In the present study, we evaluated the biochemical characteristics and immunogenicity of two H7 virus-like particles (VLPs) composed of the matrix 1 (M1) and hemagglutinin of wild-type (HA-WT) or hemagglutinin of whose transmembrane domain replaced by that from H3N2 subtype (HA-TM). H7 VLPs-WT and H7 VLPs-TM could assemble and release into the supernatant of Sf9 cells and they had similar morphological characteristics. However, compared to H7 VLPs-WT, H7 VLPs-TM had more trimeric HA proteins and could better resist thermal changes. In mice H7 VLPs-TM induced higher titers of HI, IgG, IgG2a and IFN-γ, and provided better protection against homologous and heterologous H7N9 viruses (no matter belonging to Yangtze River Delta or Pearl River Delta) challenge with less weight loss and higher survival rate. In summary, H7 VLPs-TM represents a potential strategy for the development of H7N9 vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Qin J, Zhang Y, Shen X, et al. H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice. Vaccine. 2018. PMID: 30037418. doi:10.1016/j.vaccine.2018.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。